Serum endocan levels in patients with peripheral artery disease: an exploratory cross-sectional study
Frontiers in Cardiovascular Medicine · 06.08.2026 · 13
DOI: 10.3389/fcvm.2026.1769347 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 06.08.2026. Verfasst von Canan Aydoğan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Konya Numune Hospital, Konya, Türkiye. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To explore whether circulating endocan concentrations differ between adults with imaging-confirmed peripheral artery disease (PAD) and controls without clinically evident PAD, and to generate hypotheses regarding the relationship between endocan and PAD-associated endothelial and inflammatory activity.
Methods
In this single-centre exploratory cross-sectional study, 56 patients with imaging-confirmed PAD were compared with 54 cardiovascular risk-enriched controls without clinically evident PAD based on pulse examination and handheld Doppler assessment. Serum endocan was measured by ELISA, and exploratory between-group and multivariable analyses were performed.
Results
The distributions of major cardiovascular comorbidities were statistically comparable between groups; however, the comparator group itself had a substantial cardiovascular-risk burden, including coronary artery disease in 74.1%, diabetes mellitus in 46.3%, hypertension in 59.3%, hyperlipidemia in 83.3%, and smoking in 44.4%. Mean serum endocan concentrations were numerically higher in the PAD group than in the comparator group (218.8 ± 166.9 vs. 170.5 ± 90.0 pg/mL), but the between-group difference did not reach statistical significance ( p = 0.063). PAD status was not independently associated with serum endocan following multivariable adjustment.
Conclusions
In this exploratory cohort, serum endocan concentrations were numerically higher in patients with PAD, but the between-group difference was not statistically significant and no independent association with PAD was demonstrated after adjustment. Interpretation is materially limited by the cardiovascular risk-enriched comparator population, in whom generalized endothelial activation and possible subclinical PAD may have reduced between-group separation. These findings do not validate endocan as a PAD-specific diagnostic biomarker and cannot be extrapolated to comparisons with low-risk healthy populations. Rather, they generate hypotheses for future studies using uniformly phenotyped healthy and risk-matched comparator groups.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Konya Numune Hospital, Konya, Türkiye.
- Department of Cardiology, Konya Selcuk University Medical Faculty Hospital, Konya, Türkiye.
- Department of Biochemistry, Konya Selcuk University Medical Faculty Hospital, Konya, Türkiye.
- Department of Cardiology, Selcuk University Faculty of Medicine, Konya, Türkiye.
- Department of Cardiology, Kayseri State Hospital, Kayseri, Türkiye.
- Department of Biochemistry, Konya Beyhekim Education and Research Hospital, Konya, Türkiye.
Zitieren
APA
Aydoğan, C., Tezcan, H., Aygül, N., Sivrikaya, A., Altunkeser, B. B., Tunçez, A., Toprak Su, A. M., Demir, K., & Ecer, B. (2026). Serum endocan levels in patients with peripheral artery disease: an exploratory cross-sectional study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1769347
Vancouver
Aydoğan C, Tezcan H, Aygül N, Sivrikaya A, Altunkeser BB, Tunçez A, et al. Serum endocan levels in patients with peripheral artery disease: an exploratory cross-sectional study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1769347
BibTeX
@article{Aydoan2026,
author = {Aydoğan, Canan and Tezcan, Hüseyin and Aygül, Nazif and Sivrikaya, Abdullah and Altunkeser, Bülent Behlül and Tunçez, Abdullah and Toprak Su, Aslıhan Merve and Demir, Kenan and Ecer, Büşra},
title = {Serum endocan levels in patients with peripheral artery disease: an exploratory cross-sectional study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1769347}
}
EUVIMED